Your browser doesn't support javascript.
loading
Similarities and differences of interstitial lung disease associated with pathogenic variants in SFTPC and ABCA3 in adults.
Diesler, Rémi; Legendre, Marie; Si-Mohamed, Salim; Brillet, Pierre-Yves; Wemeau, Lidwine; Manali, Effrosyni D; Gagnadoux, Frédéric; Hirschi, Sandrine; Lorillon, Gwenaël; Reynaud-Gaubert, Martine; Bironneau, Vanessa; Blanchard, Elodie; Bourdin, Arnaud; Dominique, Stéphane; Justet, Aurélien; Macey, Julie; Marchand-Adam, Sylvain; Morisse-Pradier, Hélène; Nunes, Hilario; Papiris, Spyros A; Traclet, Julie; Traore, Ibrahim; Crestani, Bruno; Amselem, Serge; Nathan, Nadia; Borie, Raphaël; Cottin, Vincent.
Afiliação
  • Diesler R; Department of Respiratory Medicine, National Reference Centre for Rare Pulmonary Diseases, Hospices civils de Lyon, Université Lyon 1, UMR754, INRAE, ERN-LUNG, Lyon, France.
  • Legendre M; U.F. de Génétique moléculaire, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Hôpital Armand Trousseau, Paris, France.
  • Si-Mohamed S; Childhood Genetic Diseases, UMR_S933, Inserm, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Hôpital Armand Trousseau, Paris, France.
  • Brillet PY; Department of Thoracic Imaging, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, INSA-Lyon, UJM-Saint-Étienne, CNRS, Inserm, CREATIS UMR 5220, Lyon, France.
  • Wemeau L; Service de Radiologie, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Bobigny, France.
  • Manali ED; CHU Lille, Service de Pneumologie et Immuno-Allergologie, Centre de Référence Constitutif des Maladies Pulmonaires Rares, Hôpital Calmette, Lille, France.
  • Gagnadoux F; 2nd Pulmonary Medicine Department, General University Hospital "Attikon," Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Hirschi S; Service de Pneumologie et Allergologie, Centre Hospitalier Universitaire d'Angers, Angers, France.
  • Lorillon G; Service de Pneumologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Reynaud-Gaubert M; National Reference Centre for Histiocytoses, Pulmonary Department, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Paris, France.
  • Bironneau V; Service de Pneumologie, Équipe de Transplantation Pulmonaire, Centre de Compétence des Maladies Pulmonaires Rares, Aix-Marseille Université, Assistance Publique-Hôpitaux de Marseille, CHU Nord, Marseille, France.
  • Blanchard E; Service de Pneumologie CHU de Poitiers, INSERM CIC 1402, IS-ALIVE Research Group, Université de Poitiers, UFR Médecine et Pharmacie, Poitiers, France.
  • Bourdin A; Service de Pneumologie, Hôpital Haut Lévêque, CHU de Bordeaux, Bordeaux, France.
  • Dominique S; Department of Respiratory Diseases and PhyMedExp, Centre National de la Recherche Scientifique, INSERM, University of Montpellier, CHU Montpellier, Montpellier, France.
  • Justet A; Department of Pneumology, CHU Rouen, Rouen, France.
  • Macey J; Service de Pneumologie, CHU de Caen, Centre de compétence des maladies pulmonaires rares, ISTCT, UMR6030-CNRS-CEA-Université de Caen, Caen, France.
  • Marchand-Adam S; Respiratory Medicine and Cystic Fibrosis Center, University Hospital Center of Bordeaux, Bordeaux, France.
  • Morisse-Pradier H; Service de Pneumologie et Explorations Fonctionnelles Respiratoires, CHU Tours, Université François Rabelais, Tours, France.
  • Nunes H; Department of Pneumology, CHU Rouen, Rouen, France.
  • Papiris SA; Service de Pneumologie et Oncologie Thoracique, Centre Constitutif Maladies Pulmonaires Rares de l'Adulte, Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Paris, France.
  • Traclet J; 2nd Pulmonary Medicine Department, General University Hospital "Attikon," Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Traore I; Department of Respiratory Medicine, National Reference Centre for Rare Pulmonary Diseases, Hospices civils de Lyon, Université Lyon 1, Lyon, France.
  • Crestani B; Service de Pneumologie, CHU Jean Minjoz, Besançon, France.
  • Amselem S; Service de Pneumologie, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris, France.
  • Nathan N; U.F. de Génétique moléculaire, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Hôpital Armand Trousseau, Paris, France.
  • Borie R; Childhood Genetic Diseases, UMR_S933, Inserm, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Hôpital Armand Trousseau, Paris, France.
  • Cottin V; Childhood Genetic Diseases, UMR_S933, Inserm, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Hôpital Armand Trousseau, Paris, France.
Respirology ; 29(4): 312-323, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38345107
ABSTRACT
BACKGROUND AND

OBJECTIVE:

Variants in surfactant genes SFTPC or ABCA3 are responsible for interstitial lung disease (ILD) in children and adults, with few studies in adults.

METHODS:

We conducted a multicentre retrospective study of all consecutive adult patients diagnosed with ILD associated with variants in SFTPC or ABCA3 in the French rare pulmonary diseases network, OrphaLung. Variants and chest computed tomography (CT) features were centrally reviewed.

RESULTS:

We included 36 patients (median age 34 years, 20 males), 22 in the SFTPC group and 14 in the ABCA3 group. Clinical characteristics were similar between groups. Baseline median FVC was 59% ([52-72]) and DLco was 44% ([35-50]). An unclassifiable pattern of fibrosing ILD was the most frequent on chest CT, found in 85% of patients, however with a distinct phenotype with ground-glass opacities and/or cysts. Nonspecific interstitial pneumonia and usual interstitial pneumonia were the most common histological patterns in the ABCA3 group and in the SFTPC group, respectively. Annually, FVC and DLCO declined by 1.87% and 2.43% in the SFTPC group, respectively, and by 0.72% and 0.95% in the ABCA3 group, respectively (FVC, p = 0.014 and DLCO , p = 0.004 for comparison between groups). Median time to death or lung transplantation was 10 years in the SFTPC group and was not reached at the end of follow-up in the ABCA3 group.

CONCLUSION:

SFTPC and ABCA3-associated ILD present with a distinct phenotype and prognosis. A radiologic pattern of fibrosing ILD with ground-glass opacities and/or cysts is frequently found in these rare conditions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Cistos / Fibrose Pulmonar Idiopática Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Cistos / Fibrose Pulmonar Idiopática Idioma: En Ano de publicação: 2024 Tipo de documento: Article